CSBR:NASDAQ
Champions Oncology Inc
USD 4,68
0,00%
(0,00) 1D
16 Nov., 15:19:28 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Mkt. cap
65,14 m
Avg. vol.
7,80 k
Volume
8,00
52-wk high
USD 8,31
52-wk low
USD 4,52
EPS
-USD 0,08
Beta
0,47
Shares outstanding
13,92 m
No. of employees
217
Mkt. cap
65,14 m
Avg. vol.
7,80 k
Volume
8,00
52-wk high
USD 8,31
52-wk low
USD 4,52
EPS
-USD 0,08
Beta
0,47
Shares outstanding
13,92 m
No. of employees
217
News stories
From web sources and news partners
ChartMill
·
1 uur gelede
S&P 500 Premarket Movers on Nov. 17: Gainers and Losers
The Motley Fool
·
34 minute gelede
Prediction: Dec. 9 Will Mark a Turning Point for the S&P 500
FOREX.com
·
1 uur gelede
S&P 500 forecast: Why US stocks have largely defied gravity and what could trigger a correction
Traders Union
·
51 minute gelede
S&P 500 could deliver 18% total return by 2027, Goldman Sachs projects
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, Verenigde State van Amerika
SectorHealth Care
Industry-
Websitechampionsoncology.com